REVIEW
Accepted on 27 Jan 2025
Targeting the PI3K/AKT/mTOR Pathway in Lung Cancer: Mechanisms and Therapeutic Targeting1
doi 10.3389/fphar.2025.1516583
- Frontiers in Pharmacology
- Respiratory Pharmacology
- Research Topics
- Therapeutic Advances in Lung Cancer and Chronic Inflammatory Lung Disease
Therapeutic Advances in Lung Cancer and Chronic Inflammatory Lung Disease
5,983
Total downloads
20k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
MINI REVIEW
Published on 20 Jan 2025
The potential role of nanobodies in asthma therapy
doi 10.3389/fphar.2024.1510806
- 219 views
ORIGINAL RESEARCH
Published on 13 Jan 2025
CD146 promotes resistance of NSCLC brain metastases to pemetrexed via the NF-κB signaling pathway
doi 10.3389/fphar.2024.1502165
- 303 views
ORIGINAL RESEARCH
Published on 07 Jan 2025
Uvaol attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells by modulating expression and membrane localization of β-catenin
doi 10.3389/fphar.2024.1504556
- 254 views
REVIEW
Published on 03 Jan 2025
Mitochondrial quality control: a pathophysiological mechanism and potential therapeutic target for chronic obstructive pulmonary disease
doi 10.3389/fphar.2024.1474310
- 358 views
CASE REPORT
Published on 24 Dec 2024
Recurrent pneumothoraces caused by a high-grade lung carcinoma with trophoblastic differentiation: a case report
doi 10.3389/fonc.2024.1462865
- 408 views
CASE REPORT
Published on 22 Nov 2024
Rare cancer with primary pleural epithelioid hemangioendothelioma diagnosed by thoracoscopic biopsy achieving disease control after 16 months: case report and literature review
doi 10.3389/fphar.2024.1482154
- 317 views
REVIEW
Published on 18 Oct 2024
Attenuating mitochondrial dysfunction-derived reactive oxygen species and reducing inflammation: the potential of Daphnetin in the viral pneumonia crisis
doi 10.3389/fphar.2024.1477680
- 699 views
REVIEW
Published on 01 Oct 2024
Diagnosis and management of multiple primary lung cancer
doi 10.3389/fonc.2024.1392969
- 721 views
REVIEW
Published on 30 Aug 2024
Lung fibrosis in sarcoidosis. Is there a place for antifibrotics?
doi 10.3389/fphar.2024.1445923
- 2,146 views
ORIGINAL RESEARCH
Published on 08 Aug 2024
Long-term effects of mepolizumab in patients with severe eosinophilic asthma: a 6-year real-life experience
doi 10.3389/fphar.2024.1449220
- 1,275 views
- 1 citation
POLICY AND PRACTICE REVIEWS
Published on 06 Aug 2024
Breaking down barriers to COPD management in primary care: applying the updated 2023 Canadian Thoracic Society guideline for pharmacotherapy
doi 10.3389/fmed.2024.1416163
- 1,496 views
Published in
Frontiers in Pharmacology
- Respiratory Pharmacology
- Inflammation Pharmacology
Impact
- 20kTopic views
- 13kArticle views
- 5,983Article downloads